sFlt- 1, PIGF, and Niacin Levels in Women With Premature Ovarian Insufficiency (POİ&niacin)
Soluble Fms-like Tyrosine Kinase-1, Proangiogenic Protein Placental Growth Factor, and Niacin Levels in Women With Premature Ovarian Insufficiency
Sponsor: Cengiz Gokcek Women's and Children's Hospital
This observational or N/A phase trial investigates Premature Ovarian Insufficiency and is currently completed. Cengiz Gokcek Women's and Children's Hospital leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Sep 2021 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Jan 2021 — Sep 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting
First recorded
Nov 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cengiz Gokcek Women's and Children's Hospital
For direct contact, visit the study record on ClinicalTrials.gov .